Short biography of Dr. Andrew Odhiambo

Dr. Andrew Odhiambo FRCP
MBChB, MMed(Int.Med), MedOnc(UK), FRCP, FCP (ECSA)
Consultant Physician & Medical Oncologist
Program Director & Lecturer University of Nairobi (UON)

dr_andrew_bio_2021_long.pdf24.29 KB



Chiorean, GE, Nandakumar G, Fadelu T, Temin S, Alarcon-Rozas AE, Bejarano S, Croitoru A-E, Grover S, Lohar PV, Odhiambo A, Park SH, Garcia ER, Teh C, Rose A, Zaki B, Chamberlin MD.  2020.  Treatment of Patients With Late-Stage Colorectal Cancer: ASCO Resource-Stratified GuidelineTreatment of Patients With Late-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline. Journal of Global Oncology. 6(2020):414-438.


Caroline, T, Elijah O, Nicholas A, Emma K, Benard G, Andrew O.  2019.  Prevalence of Anthracycline Induced Cardiomyopathy amongstCancer Patients Treated at Tertiary Teaching and Refferal Hospital in Nairobi Kenya. International Journal of Scientific Research and Management (IJSRM) . 7(12):2321-3418.


Habib, A, Odhiambo A, Othieno-Abinya N, Maina JMD.  2018.  Prevalence of Deep Venous Thrombosis in Cancer Patients Admitted to the Medical Wards at the Kenyatta National Hospital. International Journal of Creative Research and Studies. 2(2):50-56. Abstract

The objectives of this study were to establish the prevalence of DVT in cancer patients at KNH medical and oncology wards, to describe patient characteristics of those with DVT vs those without and compare rates of DVT in different types of cancer. This was a cross-sectional descriptive study carried out at the Kenyatta National Hospital general medical wards and oncology wards. Patients were interviewed and examined. Patients’ records were perused for information relevant to the study. Patients with history and physical examination findings suggestive of a thrombotic event were screened by compression sonography to confirm a DVT. A total of 266 patients with a diagnosis of cancer were studied, 29 (10.9%) had DVT. Among the patients who were found to have DVT, 13 (44.8%) had gynaecological cancers, 3 (10.3%) breast cancer, 3(10.3%) prostate cancer, 3(10.3%) gastric cancer, 2(6.9%) patients had lymphoma and a patient (3.4%) each in the multiple myeloma, adenocarcinoma, squamous cell carcinoma and pancreatic cancer groups. Some significant patient characteristics in the patients who had a DVT were female sex (P value 0.014), presence of comorbidities (P 0.004) and ECOG scores of 3 and 4 (P 0.04, 0.001). Some common risk factors known for DVT were analysed and some were found to be significant in our patient group. Of the significant risk factors,
presence of comorbid condition, female sex and higher ECOG scores were noted. Keywords: DVT, VTE, ECOG, Comorbidities, Kenyatta National Hospital
Venous thromboembolic events in cancer are quite common and are a leading cause of morbidity, delays in care and death. As cancer is a heterogeneous disease, the risk of DVT depends on cancer types and stages, treatment
measures, and patient-related factors

Oyiro, P, Mwanda W, Odhiambo A, Ogutu E, Otieno CF, Abdalla F.  2018.  Serum Ferritin Levels In Patients with Sickle Cell Anaemia at the Kenyatta National Hospital. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS). 17(3):31-40.serum_ferritin_sickle_cell_knh.pdf
Wambui, A, ODHIAMBO A, Achieng L, Otieno CF, Bhatt SM.  2018.  Prevalence of Vitamin D Deficiency in Adult Human 
Immunodeficiency Virus Infected Persons at District Hospital in Nairobi, Kenya. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS). 17(3):70-75.vitamin_d_deficiency_in_hiv.pdf


Abinya, NA, Mwanda WO, Maina JMD, Odhiambo AO, Oyiro PO, Mwanzi SA, Dindi E, Waweru A.  2017.  Exploring Occupational and Familial Risks for Chronic Myeloid Leukaemia. Journal of US-China Medical Science . 1(14):31-35.cml_risk_us-china_publ.pdf


Njoroge, J, Oyoo GO, Kitonyi G, Barasa A, Odhiambo AO.  2016.  Haematological parameters in systemic lupus erythematosus patients at Kenyatta National Hospital, Nairobi. African Journal of Rheumatology. 4(2):57-62. Abstracthaematological parameters SLEWebsite


Systemic lupus erthematosus (SLE) is a multisystem, autoimmune and often severe disease. Its aetiology is still poorly understood. Factors such as genetic, environmental, hormonal and immunological have been implicated in its pathogenesis. Patients with SLE are subject to myriad symptoms, complaints, and inflammatory involvement that can affect virtually every organ including the hemopoietic system.
Hematological abnormalities are common among patients with SLE. The most frequent hematological abnormalities include anemia, leucopenia and thrombocytopenia. These abnormalities are markers of disease activity and have been found to be independent determinants of mortality therefore understanding their prevalence is important in patient evaluation.

While these abnormalities have been widely studied in other parts of the world, no study has been conducted on Kenyan patients afflicted by SLE thus there exist a gap regarding hematological parameters in SLE patients and hence the need for this study. We performed this study to understand hematological parameters in a tertiary hospital in Nairobi, Kenya.

The main objective of this study was to determine the prevalence of hematological parameters abnormalities, among SLE patients on follow up at Rheumatology and Renal Outpatient clinics at Kenyatta National Hospital. Specifically, the study aimed to describe the prevalence of anemia, leucopenia, and thrombocytopenia and identify patient factors associated with these abnormalities.


A cross-sectional descriptive study was carried out on SLE patients attending the Rheumatology and Renal outpatient clinics at KNH. Seventy one consecutive SLE patients were screened for eligibility between 5th March 2015 and 5th of June 2015, of these sixty five were recruited and enrolled into the study. Clinical and social demographic data was captured and recorded in a pre-designed questionnaire. Subsequently, four millilitres of blood was collected for measurement of a complete blood count, reticulocyte count, erythrocyte sedimentation rate and peripheral blood film examination. The tests were undertaken at the KNH Department of Human Pathology, Unit of Haematology and blood transfusion using a CELL-DYN 3700 automated blood counter. ESR interpretation was undertaken at the same laboratory by the Wintrobe method and a PBF was reported after staining with maygrunwald / giemsa stain by direct visualization on a microscope at various powers of magnification by hematologists who were supervisors for this study and the PI


Sixty five eligible SLE patients were recruited into the study. The mean (SD) age was 36. 5(± 12) years. There were 3 (5%) males and 62 (95%) females. Forty nine (75%) patients had at least one abnormality. The abnormalities involved all the three cell lines. The prevalence of abnormalities were; anemia 43%, leucopenia 26% and thrombocytopenia 20%. Disease duration less than one year was significantly associated with anemia, p=0.035, OR = 3.5 (95% CI 0.9-15.1).


Hematological abnormalities are the second most common manifestation of the disease after arthritis and arthralgia among SLE patients on follow up at Kenyatta National Hospital Rheumatology and Renal clinic. Though majority of these abnormalities were mild to moderate and clinically asymptomatic, the proportions of anemia, leucopenia and thrombocytopenia were substantially high. There was a significant association between anemia and duration of disease.


I. A larger longitudinal study to correlate thrombocytopenia and leucopenia with demographics and drugs. . This may require a multicenter approach to avail sufficient number of patients.
II. Routine screening for hematological abnormalities, careful long-term monitoring and prompt therapeutic intervention.
III. Multidisplinary approach in management of SLE patients and input from a hematologist.
IV. Need to review the current treatment regimens of our patients to a steroid sparing regimen.
V. Lastly a study to correlate these hematological abnormalities with disease activity in patients with SLE.



Odhiambo, AO, Kiarie GG, Joshi MD, Ngugi PM.  2014.  Serum Vitamin D profile in black African men with Prostate Cancer in a tertiary refferal facility in sub-saharan Africa. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS). 13(4 vers III):60-64., Nairobi: University of Nairobi Abstractvitamin_d_prostate_cancer_iosr_jdms.pdf


Background: Considerable epidemiological, in vitro, in vivo and clinical data support an association between vitamin D deficiency and prostate cancer risk and outcome. Few studies have examined this association in African men with prostate cancer.The vitamin D status in patients with prostate cancer in Kenya is unknown. This study aimed to determine the profile of vitamin D levels in patients with prostate cancer and to correlate this to patient and disease characteristics.

Methods: Hospital-based cross-sectional study that evaluated black African men with incident or 3-month prevalent histologically confirmed prostate cancer seeking ambulatory care at KNH. Medical history was obtained by direct interview and the information recorded in questionnaires. Treatment history, pre-diagnostic serum PSA and Gleason score were abstracted from patient records. Every participant had their anthropometric measurements taken and plasma samples drawn for 25-hydroxyvitamin D (25-VD) concentrations using the LIAISON® 25-OH automated chemiluminescent immunoassay method. The relationship between age, body mass index, pre-diagnostic serum PSA and Gleason score on vitamin D status was evaluated using bivariate and multivariate analysis.

Results: 162 black African men were evaluated. The mean 25-VD was 19.15 ng/ml and 144 (88.9%) men had vitamin D deficiency (25-VD < 30ng/ml). 29 (17.9%) were severely deficient (25-VD < 10ng/ml), 115 (71%) were moderately deficient (10-<30 ng/ml) and 18 (11.1%) were normal (30-100ng/ml). Gleason scores >7 (OR 2.9; 95% CI 1.5-5.5, p = 0.001) and serum PSA ≥ 50ng/ml (OR 2.2; 95% CI 1.7-5.1, p = 0.014) were associated with vitamin D deficiency (25-VD < 20ng/ml) whereas age and BMI were not. Adjusted for age, BMI and serum PSA levels, having Gleason scores > 7 was independently associated with vitamin D deficiency (OR 2.5; 95% CI 1.2 – 4.9, p = 0.01).

Conclusion: Vitamin D deficiency is very common in black African men with prostate cancer, particularly in those with higher Gleason scores.

UoN Websites Search